Pharmaceutical IP and competition law in the Russian Federation: overview | Practical Law

Pharmaceutical IP and competition law in the Russian Federation: overview | Practical Law

A Q&A guide to pharmaceutical IP and competition law in the Russian Federation.

Pharmaceutical IP and competition law in the Russian Federation: overview

Practical Law Country Q&A 0-618-7826 (Approx. 18 pages)

Pharmaceutical IP and competition law in the Russian Federation: overview

by Natalia Gulyaeva, Julia Gurieva, Natalia Spitsyna and Elizaveta Semenova, Hogan Lovells CIS
Law stated as at 01 Mar 2021Russian Federation
A Q&A guide to pharmaceutical IP and competition law in the Russian Federation.
The Q&A gives a high level overview of key issues including patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports.
For information on pharmaceutical pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability, visit Medicinal product regulation and product liability in the Russian Federation: overview.